Reviewing Life Sciences Testimonials, KOL Videos and Social Claims
Build a claims review workflow for testimonials, KOL videos and social promotion using U.S. FTC and FDA rules and EU advertising requirements.
Expert insights on AI visibility, SEO strategy, and growth tactics for life sciences companies.
Focused articles on AI visibility, SEO, and sustainable growth for life sciences companies.
Build a claims review workflow for testimonials, KOL videos and social promotion using U.S. FTC and FDA rules and EU advertising requirements.
Get the latest insights on AI visibility and life sciences marketing delivered to your inbox.
No spam. Unsubscribe anytime.
Keep US and China device identifiers, intended-use evidence and digital advertising approvals aligned through a controlled product and claims record.
Align FDA correction and removal reporting, consignee notices, public warnings and Early Alerts with a documented website publishing handoff.
Use FDA guidance, enforcement cases and classification data to distinguish wellness, device and software claims across websites, interfaces and communications.
Separate Form 6-K filing rules, English translations and incorporation by reference from the life-sciences communications workflow and its review record.
Reconcile FDA’s SIUU implementation notice with later OMB approvals, then classify life-sciences communications and preserve review across derivative content.
Compare life-sciences filings from the year 2026: required announcement text, other exhibits, furnished versus filed treatment and disclosure deadlines.
EU AI Act Article 50(4) applies from 2 August 2026. Sort five AI-written life-sciences outputs and see the review record that lets a disease page skip the label.
Audit 64 research artifacts and 188 brand snapshots to plan useful MedTech content, maintain its evidence and measure search, citations and qualified demand.
Audit FDA status wording across device pathways, websites, press releases and AI answers, with a practical claims matrix and clearly bounded evidence.
An 188-domain audit tests crawler policies, page access and metadata, then turns bounded source panels into a practical MedTech website release checklist.
A 40-market evidence model turns trade, access, language, digital readiness, and delivery constraints into a practical website localization sequence.
We joined NIH device awards, FDA 510(k)s, federal contracts, and ten public registers to measure the public-evidence gap after funding and clearance.
We analyzed 40 capped AI recommendation panels, 1,689 citations, and 188 brand reports to show what an AI shortlist does—and does not—measure.
We audited six life-sciences PR Newswire campaigns: 1,159 pickups, crawler traffic, link markup, AI citations, durability, and click economics.
We rebuilt our own $200,000-$300,000 comparison claim from federal wage data. A realistic in-house configuration costs $220,888 a year - and here is every line of the arithmetic.
A 60-company audit reveals where newly cleared MedTech websites break between FDA records, product findability, regulatory evidence, and buyer inquiry.